Invesco’s Aratana Therapeutics PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-160,933
Closed -$1.16M – 3785
2016
Q4
$1.16M Buy
+160,933
New +$1.3M ﹤0.01% 2917
2015
Q3
– Sell
-392
Closed -$6K – 4135
2015
Q2
$6K Buy
+392
New +$5.66K ﹤0.01% 4158

Other funds holding PETX

Invesco's PETX Position: Q1 2017 in Review

Invesco sold out of Aratana Therapeutics (PETX) in Q1 2017, closing a stake of 160,933 shares — an estimated $1.16M sold.

Invesco first reported a position in PETX in Q2 2015 and held it in 2 quarters. The position peaked at $1.16M in Q4 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

  • Invesco reported no remaining Aratana Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Invesco sold 160,933 Aratana Therapeutics shares in Q1 2017, an estimated $1.16M.
  • Invesco first reported a position in Aratana Therapeutics in Q2 2015 and held it in 2 quarters.
  • Invesco's Aratana Therapeutics position peaked at $1.16M in Q4 2016.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.